PSTX   $3.37  -6.65% Market Closed After Close 3.4 0.89%

Poseida Therapeutics Inc
Total Cash 237.81M
totalCashPerShare 2.449
EBITDA -112.86M
Total Debt 83.65M
quickRatio 2.443
currentRatio 2.483
Total Revenue 88.46M
debtToEquity 137.549
Revenue/Share 0.93
ROA -0.25536
ROE -1.15004
grossProfits
freeCashflow -751.00K
operatingCashflow 2.46M
earningsGrowth
revenueGrowth 0.298
grossMargins -0.77228
ebitdaMargins -1.2757801
operatingMargins -1.22265
profitMargins -1.2748101
enterpriseValue 144.00M
forwardPE -1.6956521
floatShares 64.35M
sharesOutstanding 97.13M
sharesShort 3.90M
sharesShortPriorMonth 3.14M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.28%
heldPercentInstitutions 0.55%
Short Ratio help_outline 10.18%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 0.626
Price To Book help_outline 4.98
earningsQuarterlyGrowth
netIncomeToCommon -112.77M
trailingEps -1.18%
forwardEps -1.84%
enterpriseToEbitda -1.28
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.41 3Q 2024
institutionsCount 131
lastUpdated Sept. 16, 2024, 7:57 p.m.